Dobutamine/milrinoneLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1949卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36159-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：179 / 179

相关论文

共 50 条

[21] Esmolol/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2020, 1827 (1) :142-142

[22] Imatinib/milrinoneLack of efficacy : case report [J].

Reactions Weekly, 2024, 2021 (1) :245-245

[23] Furosemide/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2021, 1839 (1) :145-145

[24] Epoprostenol/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2025, 2050 (1) :226-226

[25] Epinephrine/MilrinoneLack of efficacy : case report [J].

Reactions Weekly, 2024, 2019 (1) :181-181

[26] Epoprostenol/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2022, 1925 (1) :240-240

[27] Epinephrine/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2020, 1822 (1) :131-131

[28] Digoxin/milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2021, 1883 (1) :154-154

[29] Bivalirudin/furosemide/milrinoneLack of efficacy : case report [J].

Reactions Weekly, 2024, 2018 (1) :91-91

[30] Norepinephrine, vasopressin and milrinoneLack of efficacy: case report [J].

Reactions Weekly, 2021, 1856 (1) :324-324

← 1 2 3 4 5 →